A phase II trial of temozolomide as a 6-week, continuous, oral schedule in patients with advanced soft tissue sarcoma: A study by the spanish group for research on sarcomas

  1. Garcia Del Muro, X.
  2. Lopez-Pousa, A.
  3. Martin, J.
  4. Buesa, J.M.
  5. Martinez-Trufero, J.
  6. Casado, A.
  7. Poveda, A.
  8. Cruz, J.
  9. Bover, I.
  10. Maurel, J.
Aldizkaria:
Cancer

ISSN: 0008-543X

Argitalpen urtea: 2005

Alea: 104

Zenbakia: 8

Orrialdeak: 1706-1712

Mota: Artikulua

DOI: 10.1002/CNCR.21384 GOOGLE SCHOLAR